Skip to main content

Table 1 Demographic and clinical characteristics of men and women on MMT

From: Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences

Variable

Men (n = 414)

Women (n = 363)

p value

Age in years (SD)

39.07 (11.72)

36.88 (10.27)

0.006

Ethnicity (% Caucasian)

347 (84.6%)

288 (80.2%)

0.127

Marital status

 Never married (%)

203 (49.0%)

158 (43.5%)

0.079

 Married/common law/living with partner (%)

129 (31.2%)

109 (30.0%)

 

 Widowed/separated/divorced (%)

82 (19.8%)

96 (26.4%)

 

Education

 Less than grade 9 (%)

88 (21.4%)

68 (18.9%)

0.008

 Grade 9–12 (%)

233 (56.6%)

177 (49.2%)

 

 Trade school, college, university (%)

91 (22.1%)

115 (31.9%)

 

Employment (% currently working)

175 (42.3%)

98 (27.0%)

<0.001

Smoking status (% current smoker)

336 (81.2%)

320 (88.2%)

0.007

Age of onset of opioid use in years (SD)

24.90 (8.90)

25.00 (8.11)

0.881

Methadone dose in mg/day (SD)

78.15 (48.36)

72.34 (42.63)

0.079

Current treatment duration in years (SD)

4.10 (4.11)

3.98 (4.15)

0.704

Physical functioning (SD)

14.45 (7.74)

16.79 (7.38)

<0.001

Psychological functioning (SD)

12.33 (8.82)

15.11 (9.36)

<0.001

Cannabis use (% cannabis users)

247 (59.7%)

158 (43.5%)

<0.001

Days cannabis use in last 30 (SD)

11.97 (13.54)

7.44 (12.02)

<0.001

Average cannabis dose in g/day (SD)

1.48 (1.71)

1.04 (1.03)

0.004

  1. Maximum score for the MAP physical and psychological functioning is 40, with higher scores indicating worse functioning
  2. SD standard deviation